Indefinite Delivery Contract 75D30119D03772

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency within the Department of Health and Human Services, to Seqirus USA Inc. The contract has a ceiling value of $27,015,000 and is for the delivery of adult influenza vaccines for the 2019-2020 flu season.

Seqirus USA Inc., through its Seqirus USA, Inc. division, is a global biotechnology company specializing in the development, manufacturing, and delivery of influenza vaccines. This IDC enables the CDC to place orders for a variety of influenza vaccine products from Seqirus as needed, including multi-dose vials, pre-filled syringes, and specialized vaccines for different age groups. Seqirus also holds several other high-value IDCs and IDIQ contracts with federal agencies such as the Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service to provide large-scale influenza vaccine supplies across various government health programs.